Appendix 3B

Name of entity

Metminco Limited

ABN

43 119 759 349

1

+Class of +securities issued or to be issued

Unlisted options expired

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

500,000 unlisted options expired

3

Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

250,000 options exercisable at A$0.089 expiring no later than 28 January 2016.

250,000 options exercisable at A$0.075 expiring no later than 28 January 2016

4

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

If the additional securities do not rank equally, please state:

· the date from which they do

· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

n/a

5

Issue price or consideration

n/a

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

n/a

7

Dates of entering +securities into uncertificated holdings or despatch of certificates

n/a

Number

+Class

8

Number and +class of all +securities quoted on ASX (including the securities in clause 2 if applicable)

2,975,335,799

Fully paid ordinary

Shares

Number

+Class

9

Number and +class of all +securities not quoted on ASX (including the securities in clause 2 if applicable)

5,000,000

522,496,459

Options exercisable at A$0.0302 expiring no later than 1 August 2017

Options exercisable at A$0.005 (GBP£0.0026) per share expiring no later than 15 May 2016

10

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

The Company does not anticipate payment of dividends in the near term.

11

Is security holder approval required?

n/a

12

Is the issue renounceable or non-renounceable?

n/a

13

Ratio in which the +securities will be offered

n/a

14

+Class of +securities to which the offer relates

n/a

15

+Record date to determine entitlements

n/a

16

Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?

n/a

17

Policy for deciding entitlements in relation to fractions

n/a

18

Names of countries in which the entity has security holders who will not be sent new offer documents

Note: Security holders must be told how their entitlements are to be dealt with.

Cross reference: rule 7.7.

n/a

19

Closing date for receipt of acceptances or renunciations

n/a

20

Names of any underwriters

n/a

21

Amount of any underwriting fee or commission

n/a

22

Names of any brokers to the issue

n/a

23

Fee or commission payable to the broker to the issue

n/a

24

Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders

n/a

25

If the issue is contingent on security holders' approval, the date of the meeting

n/a

26

Date entitlement and acceptance form and offer documents will be sent to persons entitled

n/a

27

If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders

n/a

28

Date rights trading will begin (if applicable)

n/a

29

Date rights trading will end (if applicable)

n/a

30

How do security holders sell their entitlements in full through a broker?

n/a

31

How do security holders sell part of their entitlements through a broker and accept for the balance?

n/a

32

How do security holders dispose of their entitlements (except by sale through a broker)?

n/a

33

+Issue date

n/a

34

Type of securities

(tick one)

(a)

Securities described in Part 1

(b)

All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Tick to indicate you are providing the information or documents

35

If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders

36

If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

To be provided after completion of rights issue

37

A copy of any trust deed for the additional +securities

38

Number of securities for which +quotation is sought

n/a

39

Class of +securities for which quotation is sought

n/a

40

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

If the additional securities do not rank equally, please state:

· the date from which they do

· the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

· the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

n/a

41

Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

(if issued upon conversion of another security, clearly identify that other security)

n/a

Number

+Class

42

Number and +class of all +securities quoted on ASX (including the securities in clause 38)

n/a

n/a

·

The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

·

There is no reason why those +securities should not be granted +quotation.

·

An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

·

Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

·

If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.